Lee Ainslie’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$271M Buy
1,984,554
+465,749
+31% +$57.2M 2.39% 16
2026
Q1
$179M Buy
+1,518,805
New +$212M 2.06% 22
2021
Q2
Sell
-1,140
Closed -$222K 816
2021
Q1
$222K Buy
+1,140
New +$234K ﹤0.01% 481

Other funds holding RGEN

Lee Ainslie's RGEN Position: Q2 2026 in Review

Lee Ainslie increased its Repligen (RGEN) stake by 31% in Q2 2026, buying an estimated $57.2M and bringing the position to 1,984,554 shares worth $271M. The position accounts for 2.39% of the portfolio, ranked #16.

Lee Ainslie first reported a position in RGEN in Q1 2021 and has held it in 3 quarters since. 476 funds tracked by Wall St. Rank hold RGEN as of Q2 2026.

  • Lee Ainslie held 1,984,554 shares of Repligen worth $271M as of Q2 2026.
  • Lee Ainslie bought 465,749 Repligen shares in Q2 2026, an estimated $57.2M.
  • Repligen made up 2.39% of Lee Ainslie's portfolio in Q2 2026, its #16 holding.
  • Lee Ainslie first reported a position in Repligen in Q1 2021 and has held it in 3 quarters since.
  • 476 funds tracked by Wall St. Rank held Repligen as of Q2 2026.

Based on Maverick Capital's 13F filing for Q2 2026, filed 14 Aug 2026.